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Parkinson’s disease (PD) is a complex neurodegenerative disease whose etiology has not
been completely characterized. Many cellular processes have been proposed to play a
role in the neuronal damage and loss: defects in the proteosomal activity, altered protein
processing, increased reactive oxygen species burden. Among them, the involvement
of a decreased activity and an altered disposal of mitochondria is becoming more and
more evident. The mitochondrial toxin 1-methyl-4-phenylpyridinium (MPP+), an inhibitor of
complex I, has been widely used to reproduce biochemical alterations linked to PD in vitro
and its precursor, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP), to
induce a Parkinson-like syndrome in vivo. Therefore, we performed a meta-analysis of
the literature of all the proteomic investigations of neuronal alterations due to MPP+
treatment and compared it with our results obtained with a mitochondrial proteomic
analysis of SH-SY5Y cells treated with MPP+. By using open-source bioinformatics
tools, we identified the biochemical pathways and the molecular functions mostly
affected by MPP+, i.e., ATP production, the mitochondrial unfolded stress response,
apoptosis, autophagy, and, most importantly, the synapse funcionality. Eventually, we
generated protein networks, based on physical or functional interactions, to highlight
the relationships among the molecular actors involved. In particular, we identified
the mitochondrial protein HSP60 as the central hub in the protein-protein interaction
network. As a whole, this analysis clarified the cellular responses to MPP+, the specific
mitochondrial proteome alterations induced and how this toxic model can recapitulate
some pathogenetic events of PD.
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INTRODUCTION
Parkinson’s disease (PD) is the second most common neurode-
generative disorder. It is pathologically characterized by the loss
of dopaminergic neurons in the midbrain substantia nigra pars
compacta (SNpc) and it is anatomically characterized by the
formation of intra-cytoplasmic protein aggregates called Lewy
bodies (Dauer and Przedborski, 2003; Keane et al., 2011). The loss
of dopaminergic neurons causes the appearance of motor symp-
toms, such as bradykinesia, resting tremor, rigidity, and postural
instability (Calvo andMootha, 2010). The majority of data on the
molecular mechanisms underlying neuronal degeneration comes
from studies on animal and cellular models (Alberio et al., 2012;
Blandini and Armentero, 2012). Among the biochemical path-
ways involved in neuronal loss, mitochondrial impairment has
been repeatedly demonstrated both in PD patients and PD mod-
els (Hauser and Hastings, 2013). Therefore, mitochondrial toxins
are often used to generate a specific insult in dopaminergic cells
(Yadav et al., 2012).
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride
(MPTP) was originally observed to reproduce Parkinson’s like
symptoms in heroin addicts ingesting a synthetic narcotic con-
taining the toxic substance (Davis et al., 1979; Langston and
Palfreman, 1996). MPTP is metabolized by monoamine-oxidase
(MAO)-B (Brooks et al., 1989) in astrocytes (Sedelis et al., 2000)
into an active toxic cation product, 1-methyl-4-phenylpyridinium
(MPP+), which primarily targets nigrostriatal dopaminergic neu-
rons because it is transported into cells via the dopamine trans-
porter (DAT) (Chagkutip et al., 2003). This leads to inhibition
of complex I of the electron transport chain (ETC) (Nicklas
et al., 1985; Ramsay et al., 1986) and cell death specifically
in dopaminergic neurons. This neurotoxin became of partic-
ular interest when it was found to reproduce symptomatic,
pathological, and biochemical features of PD in animal mod-
els (Tieu, 2011). The active toxic metabolite MPP+ is fre-
quently used in in vitro studies but does not cross the blood
brain barrier, thus the precursor MPTP is used to generate
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one of the most commonly used pharmacological models
of PD.
The animals most frequently used for MPTP-based studies
are mice and monkeys. The treatment with MPTP is usually
optimized to generate the least number of undesirable conse-
quences (acute death, dehydration, and malnutrition) and, at
the same time, the most severe and stable form of SNpc dam-
age (Tieu, 2011). Monkeys are more sensitive to the toxin and
often exhibit a generalized (bilateral) parkinsonian syndrome;
on the other hand, this model fails to reproduce two impor-
tant characteristic features of PD: the loss of neurons in other
brain monoaminergic areas and the formation of Lewy bodies.
Rodents, compared to monkeys, are less sensitive to MPTP tox-
icity. Nevertheless, the C57black6 mice strain was found to be
sensitive to a systemic injection of MPTP and the damage to
be selective on mesencephalic dopaminergic neurons. The use
of MPTP in rats, on the contrary, is limited because they do
not show any significant dopaminergic neurodegeneration (Tieu,
2011). The human neuroblastoma SH-SY5Y cell line (N-type) is
widely used for in vitro studies. Indeed, these cells express DAT,
required for the entry of the toxin into the cell (Alberio et al.,
2012).
Current research on the molecular bases of PD is exploit-
ing high-throughput screening techniques to detect altered neu-
ronal gene expression. However, changes in mRNA levels do
not always correlate with similar changes in protein levels or
activity (Vogel and Marcotte, 2012). Studies evaluating protein
expression changes in PD models are therefore crucial. The
most common methods of proteome analysis are the compara-
tive two-dimensional electrophoresis (2-DE), followed by mass
spectrometry (MS), and shotgun proteomics, based on a gel-free
approach (Zhao et al., 2007). Shotgun proteomics shows better
sensitivity and resolution than 2-DE, thus allowing the detec-
tion and quantification of several hundreds of proteins. However,
2-DE provides a better workbench for the characterization of
post-translational modifications, including proteolytic degrada-
tion (Alberio et al., 2014). Proteomics is an unbiased approach,
aiming at generating a list of candidate proteins deserving fur-
ther targeted studies. Such a global approach allows to manage
with the great complexity of the system being investigated (e.g.,
the brain), thus overcoming limits of conventional biochemistry
or molecular biology tools. However, it is sometimes difficult to
interpret a long list of data and solve the false positive and false
negative issues. In this regard, the integration of proteomics with
bioinformatics data mining methods can unravel the involvement
of biochemical pathways that were hidden by the complexity of
data themselves and focus the attention on the main mechanisms
responsible of the phenomena under investigation (Alberio et al.,
2014; Kaever et al., 2014).
In this study we performed a meta-analysis of all the pro-
teomic investigations of neuronal alterations due to the MPP+
treatment reported so far (Jin et al., 2005; Zhao et al., 2007; Chin
et al., 2008; Diedrich et al., 2008; Liu et al., 2008; Zhang et al.,
2010; Burté et al., 2011; Campello et al., 2013; Dixit et al., 2013;
Choi et al., 2014) and compared it with our results obtained
with a mitochondrial proteomic analysis of SH-SY5Y cells treated
with MPP+ (Alberio et al., 2014). Through this analysis, we
aim at clarifying the cellular responses to MPP+, the specific
mitochondrial proteome alterations induced and how this toxic
model can recapitulate some pathogenetic events of PD.
MATERIALS AND METHODS
INPUT LISTS GENERATION
Two input lists were generated: the first one -EXP input list-
included proteins altered in SH-SY5Y cells treated with MPP+
(2.5mM, 24 h) compared to control cells. Proteomics data were
obtained both by 2-DE and shotgun LC-MS/MS (Alberio et al.,
2014). The second META input list was obtained by a meta-
analysis of the literature by Medline search of “MPP+”AND
“proteom∗” or “MPTP∗”AND “proteom∗” keywords. All
protein IDs were converted to the corresponding human
Uniprot ID.
BIOINFORMATICS ANALYSIS
The over-representation analysis (ORA) of protein lists (EXP
and META) was carried out using the GO Consortium (http://
geneontology.org/), Reactome (http://www.reactome.org/),
and Webgestalt online tools (http://bioinfo.vanderbilt.edu/
webgestalt/) against Kyoto Encyclopedia of Genes and Genomes
(KEGG), WikiPathway and Pathway Commons databases.
The web portal BioProfiling.de was used to build enriched
networks. It covers most of the available information regard-
ing signaling and metabolic pathways (database: Reactome)
and physical protein-protein interactions (database: IntAct)
(Antonov, 2011). Accordingly, the input list was analyzed by
Rspider (Haw and Stein, 2012) and PPIspider (Antonov et al.,
2009; Orchard et al., 2014) tools, respectively. Both tools employ
advanced enrichment or network-based statistical frameworks.
The p-value provided, computed by Monte Carlo simulation
(http://www.bioprofiling.de/statistical_frameworks.html), refers
to the probability to get a model of the same quality for a random
gene list of the same size (Antonov et al., 2010).
The significant networks D1 (all nodes belong to the input list)
and D2 (the insertion of one node between two existing nodes
is allowed), p < 0.01, were further considered to interpret and
discuss proteomics results. The enriched networks were exported
as a. xgmml file and visualized and modified by Cytoscape 3.1.0
(http://www.cytoscape.org/) (Shannon et al., 2003).
To perform ORA (GO terms) and network topology anal-
ysis of the enriched networks, we used the Jepetto Cytoscape
application (Winterhalter et al., 2014; http://apps.cytoscape.org/
apps/jepetto), which interacts simultaneously with three servers,
i.e., EnrichNet, PathExpand, and TopoGSA. Significantly over-
represented GO terms were selected if their Xd score was greater
than that calculated as the intercept of the linear regression of Xd
scores vs. the Fisher’s exact test p-value after Benjamini-Hochberg
correction (q-value) (Glaab et al., 2012). The outcome of the
topological analysis considered was the statistics table, provid-
ing the averaged values for five topological properties (shortest
path length, node betweenness centrality, node degree, clustering
coefficient and node eigenvector centrality), and the similar-
ity ranking table, providing a quantitative comparison of the
uploaded dataset with the reference datasets, based on a similarity
score.
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SUBNETWORK CLUSTERING
ClusterMaker Cytoscape application (http://www.cgl.ucsf.edu/
cytoscape/cluster/clusterMaker.shtml) was employed to fragment
the META list, PPI D2 model (Morris et al., 2011). In partic-
ular, the implemented GLay algorithms were used to identify
subnetworks. The GLay environment provides layout algorithms
optimized for large networks and allows the exploration and
analysis of highly connected biological networks (Su et al.,
2010). Eventually, Webgestalt, GO consortium and Reactome
were employed to perform ORA of the segmented clusters.
RESULTS
GENERATION OF THE EXP LIST AND META LIST
The EXP list was generated by including all the proteins found to
be altered in the mitochondrial proteomics investigation of SH-
SY5Y exposed to 2.5mM MPP+ for 24 h (Alberio et al., 2014).
The list was initially not created nor analyzed in the original
paper because in that case MPP+ served as an internal control for
the dopamine treatment. Fifty-nine proteins detected both by 2-
DE and shotgun LC-MS/MS have been included (Supplementary
Table 1). For the meta-analysis of the literature, we collected
all the valuable information coming from papers where changes
at the proteome level were evaluated after MPTP or MPP+
treatment (Supplementary Table 1). Data from 11 publications
were used to build the list (META input list, 475 proteins). We
considered protein changes observed in SH-SY5Y cells (Alberio
et al., 2014; Choi et al., 2014), in the N2a mouse neuroblas-
toma cell line (Burté et al., 2011), in the MPTP-mouse midbrain
(Jin et al., 2005; Zhao et al., 2007; Chin et al., 2008; Diedrich
et al., 2008; Liu et al., 2008; Zhang et al., 2010; Dixit et al.,
2013) and in the MPTP-monkey neuronal retina (Campello et al.,
2013).
OVER-REPRESENTATION OF BIOCHEMICAL PATHWAYS AND GENE
ONTOLOGY CATEGORIES
In order to understand which cellular pathways are mainly altered
by MPP+, both the proteins of our study on SH-SY5Y cells (EXP
list) and those found in the literature (META list) were analyzed
in terms of ORA by the GO enrichment tool of the GO con-
sortium, by Webgestalt and by Reactome. Webgestalt was used
to find over-represented pathways in KEGG, WikiPathways and
Pathway Commons databases. All the results coming from the dif-
ferent analyses are detailed in Supplementary Tables 2–8. Since
the analyses gave rise to a large amount of results, we selected and
summed up the most relevant information in Table 1.
The “ATP production” pathway served as an internal con-
trol, as MPP+ directly acts on the complex I of the ETC
(Vila and Przedborski, 2003) and it is known to affect ATP
production by the mitochondria. Moreover, the ORA analy-
sis revealed that MPP+ induces apoptosis, probably through
the intrinsic, mitochondrial-dependent pathway, since it was
evidenced also by the EXP list analysis. Furthermore, MPP+
influenced mitochondrial transport, mainly through Voltage
Dependent Anion Channels (VDACs) and protein folding, induc-
ing a chaperone-mediated response. Both analyses pointed
out the involvement of the ubiquitin proteasomal system
Table 1 | Summary table of the most significant results of the GO,
Webgestalt, and Reactome analyses.
Input list
EXP META
GO biological
process
ATP production
Response to stress
Apoptosis Synapse
Mitochondrial transport Protein complex assembly
Protein folding/unfolding Neurotransmitter transport
Nervous system
development
GO molecular
function
ATP production
Structural constituent of cytoskeleton
Voltage-dependent anion
channel activity
Phosphatase activity
Transmembrane transport
activity
SNARE binding
KEGG Parkinson’s disease
Oxidative phosphorylation
Protein processing
Calcium signaling pathway
Cytoskeleton
WikiPathways ATP production
Parkin-ubiquitin proteasomal system pathway
Synaptic vesicle pathway
Signaling pathways (EGF,
Insulin, TSH, FOS, G13)
Cytoskeleton
G protein signaling
pathway
Pathway
Commons
ATP production
Apoptosis
Unfolded protein response
Metabolism
Synapse:
neurotransmitters
metabolism and release
Signaling pathways (VEGF,
Insulin, junctions, PI3K,
and mTOR, etc. . . )
Reactome HSP response to stress
ATP production
Mitochondria protein import
EPH signaling
GAP junction trafficking
L1CAM interaction
Chemical synapse
transmission
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and the role of parkin in responding to mitochondrial
stress. Additionally, the analysis of the META list highlighted
the influence of the treatment on the functionality of the
synapse, both at the structural and at the molecular level.
Eventually, several signaling pathways probably involved in
the cellular response to the toxin were shown to be over-
represented.
FUNCTIONAL NETWORK ENRICHMENT
To visualize which protein networks include the proteins altered
byMPP+, we performed a network-based analysis of the two lists,
using as reference knowledge a global gene network constructed
by combining signaling and metabolic pathways from Reactome
and KEGG (Rspider). Both D1 model, where all nodes belong
to the input list, and D2 model, the enriched network where the
insertion of one node between two existing nodes is allowed, gen-
erated by the EXP list were superimposable and included only
proteins belonging to the ETC (Figure 1A). When all the proteins
found to be altered in the literature were included (META list),
two more complex networks were generated. Figure 1B shows
only proteins of the original list (D1). Orange nodes represent
proteins involved in the synaptic transmission, revealing once
again the MPP+ influence on synaptic functionality. The same
proteins, together with others probably involved in the dysfunc-
tion at the synapse level, were present also in the D2 model
(Figure 1C, orange nodes). Moreover, putative molecular factors
responsible of guiding the cellular response (signaling pathways)
and the apoptotic process are highlighted in pink and purple,
respectively. The hexagonal nodes represent proteins of the EXP
list, which contribute to the network built with the META list.
PHYSICAL-INTERACTIONS NETWORK ENRICHMENT
As for the functional network analysis, we used a network-based
enrichment to visualize physical interactions among proteins of
the lists, using the IntAct database as the reference set (PPIspider).
Figure 2A shows the D1 model for the EXP list. The network
evidenced the alteration of proteins involved in mitochondrial
transport (red nodes), mainly guided by VDACs. By adding nodes
in the D2 model, it was possible to identify HSPD1, alias HSP60,
(octagonal node) as a hub, i.e., a central protein directing the
mitochondrial response to stress (Figure 2B). This visual rep-
resentation of physical interactions among proteins responding
to MPP+ suggests that the unfolded protein response, which is
clearly activated, is probably guided by HSP60.
Figure 2C shows the D1 model for the META list. The contri-
bution of proteins by our mitochondrial proteomics investigation
is underlined by hexagonal nodes. This network drew atten-
tion to cytoskeletal proteins perturbed by the specific challenge
(light green nodes). The D2 model of the META list (Figure 2D)
was particularly complex and significant protein subgroups were
estimated by a specific segmentation analysis. Color code is main-
tained to show processes already present in the other networks.
INTEGRATED NETWORKS ANALYSIS
The list of proteins coming from the D2 network of the EXP list
and the D1 network of the META list were analyzed by Jepetto,
a Cytoscape app querying the EnrichNet and the PathExpand
servers. Results for the analysis of the EXP list, PPI D2 model are
summarized in Table 2. The previous enrichment performed by
the network-based analysis allowed us to reveal other processes
possibly involved, such as the mTOR signaling cascade and the
regulation of the DNA repair, beyond other already identified
pathways (e.g., ATP production, Response to unfolded protein).
On the other side, the analysis of the PPI D1 model of the
META list (non-enriched model) allowed us to obtain a statistical
representation of information present in the network. Results are
shown in Table 3. The significant results included once again the
over-representation of proteins acting at the synapse and impli-
cated in the transport to mitochondria, but also highlighted new
pathways, such as autophagy. The topological analysis of this
model suggested a close interaction between nodes (Table 4). The
average shortest path length was smaller than in random net-
works, which indicates closer interactions. This was confirmed by
over two times higher average node degree.
SUBNETWORK CLUSTERING
Since the PPI D2 model for the META list was very complex, we
firstly segmented it into subnetworks using the GLay commu-
nity detection algorithms. Secondly, we performed ORA on the
proteins of each cluster, using the same tools as in the previous
analyses (i.e., GO consortium, Webgestalt, Reactome), in order
to recognize the univocal biological meaning of each topological
cluster.
Figure 3 shows the same network of Figure 2D, highlight-
ing the clusters found by GLay. Twenty-four clusters have been
originated by the original network. Since it was not possible to
interpret univocally all subnetworks, we considered only the path-
ways identified in an unambiguous way by all the analyses and
labeled them on Figure 3. Concerning cluster 12, we evidenced
the enrichment in mitochondrial proteins, as detected by ORA,
using the GO Cellular Component (CC) category. The complete
list of ORA analysis results, using GO as a reference set, is detailed
in Supplementary Table 9, whereas the outcome of theWebgestalt
and Reactome analysis is presented in Supplementary Table 10.
In summary, our analysis revealed the direct effect of MPP+
on ATP production by mitochondria; the alteration of VDACs
and the consequent dysregulation of the transport to and from
the mitochondria; the activation of the mitochondrial unfolded
stress response (mt-UPR), together with the pivotal role of HSP60
in directing it; the alteration of the synapse functionality, in
particular of the SNARE complex and proteins involved in the
endocytosis; the possible signaling cascades activated by the toxin,
e.g., EGF, MAPK; the triggering of apoptosis and the autophagy
induction.
DISCUSSION
The MPTP/MPP+ model has been widely used to reproduce a
Parkinson-like syndrome in animal models as well as mitochon-
drial impairment in cellular models. Notwithstanding this, very
few is known about which specific pathways are altered by the
toxin and how MPP+ treatment is able to recapitulate PD patho-
genesis at the cellular level. The MPTP model is particularly
suitable to study PD neurodegeneration for two main reasons: it
Frontiers in Cellular Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 14 | 4
Monti et al. MPP+ systems biology analysis
FIGURE 1 | Networks built by Rspider, using both KEGG and
Reactome databases as the reference set. (A) D1 and D2 model of
the EXP list. (B) D1 model of the META list. (C) D2 model of the
META list. Proteins from the input lists are represented by squares.
Intermediate genes added by the enrichment tool are represented by
triangles. Nodes coming from the EXP list are evidenced by hexagons
in (C). Colors indicate gene functional role according to the Gene
Ontology.
specifically affects dopaminergic neurons since its active metabo-
lite, MPP+, enters via the DAT transporter. Secondly, it acts as a
complex I inhibitor and several lines of evidence have demon-
strated an involvement of the complex I dysfunction in PD
pathogenesis. Complex I deficiency and oxidative damage have
been frequently observed in affected neurons and in peripheral
tissues of PD patients (Schapira et al., 1989; Benecke et al., 1993;
Parker and Swerdlow, 1998; Ambrosi et al., 2014). Moreover, it
has been more recently demonstrated that the enzymatic activ-
ity of complex I depends on the integrity of the kinase domain
of PINK1 (Morais et al., 2009). Consequently, also the patho-
genetic mechanisms related to the autosomal recessive PD linked
to PINK1 mutations impinges on the impairment of complex I
activity (Morais et al., 2014).
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FIGURE 2 | Networks built by PPIspider, using the IntAct database
as the reference set. (A) D1 model of the EXP list. (B) D2 model
of the EXP list. (C) D1 model of the META list. (D) D2 model of
the META list. Proteins from the input lists are represented by
squares. Intermediate genes added by the enrichment tool are
represented by triangles. Nodes coming from the EXP list are
evidenced by hexagons in (C,D). Colors indicate gene functional role
according to the Gene Ontology.
In order to exploit the large mole of data present in the
literature, we merged the results of several papers containing
proteomics experiments on different MPTP-models. With this
approach it is possible to overcome the limit of each model
or methodology used and to extrapolate the biochemical path-
ways altered by the complex I blockade. By ORA, we tried to
overcome the limits of different databases using several of them
and searching for “consensus” pathways. The ORA of the EXP list
underlined the involvement of VDACs in altering the transport
to and from the mitochondria. The importance of these channels
in determining mitochondrial function and consequently the cell
fate is the subject of many recent reports (Geisler et al., 2010;
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Table 2 | Summary table of most significant results of the Jepetto
analysis of EXP list, PPI D2 model.
Xd-score q-value Overlap/
Size
E
X
P
lis
t
P
P
ID
2
m
o
d
el
GO BIOLOGICAL PROCESS
Mitochondrial ATP synthesis coupled
proton transport
0.95734 0.03314 3/12
ATP synthesis coupled proton
transport
0.88042 0.03314 3/13
Protein deacetylation 0.75734 0.19418 2/10
Negative regulation of androgen
receptor signaling pathway
0.68461 0.19418 2/11
Negative regulation of TOR signaling
cascade
0.62401 0.19418 2/12
Cellular response to glucose starvation 0.62401 0.19418 2/12
Initiation of viral infection 0.62401 0.19418 2/12
Anion transport 0.57273 0.21262 2/13
Positive regulation of DNA repair 0.5028 0.10623 3/22
Response to unfolded protein 0.47016 0.00741 5/39
GO MOLECULAR FUNCTION
Hydrogen ion transporting ATP
synthase activity, rotational mechanism
0.62772 0.18965 2/12
Hydrogen ion trans membrane
transporter activity
0.4055 0.28498 2/18
Table 3 | Summary table of most significant results of the Jepetto
analysis of META list, PPI D1 model.
Xd-score q-value Overlap/
Size
M
E
TA
lis
t
P
P
ID
1
m
o
d
el
GO BIOLOGICAL PROCESS
Glycolysis 0.67947 0.00006 6/34
Synaptic vesicle exocytosis 0.64026 0.25401 2/12
Positive regulation of ATPase activity 0.61645 100.000 1/14
Protein targeting 0.60734 0.08782 3/27
Anion transport 0.58898 0.27769 2/13
Intra-Golgi vesicle-mediated transport 0.57359 100.000 1/15
Gluconeogenesis 0.52915 0.00153 5/36
Sarcomere organization 0.44418 0.41723 2/17
Autophagic vacuole assembly 0.42359 100.000 1/20
GO MOLECULAR FUNCTION
SNARE binding 0.83777 0.19351 2/15
Hydrolase activity, acting on
carbon-nitrogen (but not peptide)
bonds
0.69837 0.19351 2/11
Syntaxin-1 binding 0.63777 0.19351 2/12
Shoshan-Barmatz et al., 2010; Sun et al., 2012; Alberio et al.,
2014). The direct damage of ETC by MPP+ causes mitochon-
dria depolarization (Nakamura et al., 2000). The electrochemical
potential serves not only for ATP production but also for the
correct import of proteins into the organelle (Friedman and
Nunnari, 2014). Therefore, the transport is generally dysregu-
lated (Burté et al., 2011) and may further damage mitochon-
drial function. Eventually, loss of import together with the loss
of potential leads to the mitochondrial unfolded protein stress
response (mt-UPR), i.e., molecular chaperones and proteases that
promote proper protein folding, complex assembly and quality
control (Haynes and Ron, 2010). Again “protein folding” is a
GO term over-represented in our list, and proteins belonging to
pathways with a similar meaning of other databases are found
to be over-represented, too (e.g., “Regulation of HSF1-mediated
heat shock response” in Reactome, “Unfolded Protein Response”
in Pathway Commons). Since the EXP list was the result of a
mitochondrial proteomics investigation, it is straightforward that
the overrepresented pathways were mainly mitochondrial. Even
if they were general cellular pathways, they stressed the involve-
ment of these organelles in guiding cellular events. On the one
hand, this permitted us to focus on the organelle and its pro-
teome alterations; at the same time, it constituted a limit in
the understanding of the MPP+ action as a whole. Therefore,
the integration of data coming from the literature allowed us
to complete the scenario. All the analyses on the META list
pointed out the alteration of proteins involved in the synapse
functionality. As a consequence of the mitochondrial dysfunc-
tion, and of a lower ATP production, it is probable that the
synapse structure and function are prejudiced. Indeed, neurons
normally rely on oxidative phosphorylation for ATP produc-
tion rather than on glycolysis (Bolaños et al., 2010). Thus, the
energetic needs of the synapse are no more fulfilled upon an
impairment of the ETC. This may justify the effect observed at the
protein level. Moreover, mitochondria should provide ATP sup-
ply and calcium buffering locally, at the high energy-demanding
synapses (Schon and Przedborski, 2011). This is the reason for
the high number of mitochondria residing in neuronal pro-
cesses (Amadoro et al., 2014). The lack of these functions at the
synapse may be the cause of the impairment of neurotransmit-
ter synthesis and release. Additionally, it must be considered that
a direct cause-effect relationship between mitochondrial num-
ber and activity with the number and plasticity of spines and
synapses has been demonstrated, as the degeneration of synapses
as a consequence of a local loss of mitochondria (Li et al.,
2004).
The network enrichment is a powerful tool, which may help
in fixing the false negative issue. Several molecular actors should
contribute to the effects observed, but they may not be detected
by the experiments performed for several reasons (e.g., limits of
the techniques). Adding nodes to the network may reveal these
proteins and the ORA of the enriched networks may highlight
previously hidden molecular pathways. As networks generated
with Rspider are concerned, the only significant network gener-
ated with the EXP list was a four-nodes graph, which stressed
the alteration of the ATP production at the mitochondrial level
and transport of ATP in the cytosol through carriers (SLC family
members). By taking into account several reports on proteomics
investigations on cellular and animal models, though, it was
possible to obtain two extended networks. The D1model was par-
ticularly interesting because, by simplymerging the literature data
without adding any node, it evidenced the action of the mito-
chondrial toxin on the synapse functionality. Two clusters were
enriched in proteins involved in the synaptic transmission: mem-
bers of the SNARE complex and associated regulatory proteins
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Table 4 | Topological analysis of the META list, PPI D1 model, using TopoGSA.
SPLa NBb Dc CCd ECe
M
E
TA
lis
t
P
P
ID
1
m
o
d
el
Data set 3.8 49153 19.03 0.08 0.03
Rand sim 4.13 ± 0.02 15506 ± 2480 8.3 ± 0.59 0.11 ± 0.01 0.02 ± 0
Entire network 4.12 ± 0.94 14669 ± 68893 8.27 ± 16.2 0.11 ± 0.21 0.02 ± 0.04
aSPL, shortest path length.
bNB, node betweenness centrality.
cD, node degree.
d CC, clustering coefficient.
eEC, node eigenvector centrality.
FIGURE 3 | Subnetwork clustering of the D2 model of the META list, using the community detection algorithms of GLay. Subnetworks are evidenced
by different colors and numbered. Unambiguously over-represented categories are indicated. See Supplementary Tables 9, 10 for details.
or adaptor proteins for the vesicles endocytosis, responsible for
the neurotransmitter re-uptake and release. The D2 model fur-
ther enlarged the view, integrating those proteins with others
involved in the signaling pathways, in the triggering of apopto-
sis and in ATP production. The proteins of the EXP list were
evidenced by a hexagonal shape to show how our experimental
findings contributed to the state-of-the-art. Apoptosis induction
was frequently observed after MPP+ treatment (Liu et al., 2008;
Bové and Perier, 2012; Campello et al., 2013; Alberio et al., 2014),
but a focus on the proteins involved in the process can reveal
which molecular mechanisms are specifically responsible for the
MPP+-induced dopaminergic neurons death.
The PPI analysis of both lists gave rise to quite complex net-
works. Apart from the D1 model of the EXP list, which evidenced
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once again the central role of VDACs, the other networks were
too complex to be evaluated by simply considering the edges
generated and the enriched categories identified on the net-
work by Bioprofiling. However, networks built using physical
interaction information may provide valuable insights when ana-
lyzed in terms of over-representation of functional categories.
Consequently, we analyzed them by creating a list with all the
nodes included in the D2 model of the EXP list and the D1 model
of the META list and by searching for over-represented GO cat-
egories, while the much larger D2 model of the META list was
analyzed after segmentation in subnetworks. The D2 model of
the EXP list showed a peculiar topology, since all the network
branches originated from a central hub, namely HSPD1 (alias
HSP60). In PPI networks hubs may represent higher-order com-
munication points between protein complexes (Han et al., 2005).
Indeed, this visual representation of data was able to evidence
the pivotal role of HSP60 in directing the mt-UPR. The nuclear
encoded chaperone HSP60 is induced by the presence of unfolded
proteins inside the organelle (Jovaisaite et al., 2014), and was
revealed to be up-regulated after MPP+ treatment by our mito-
chondrial proteomics analysis. Accumulating unfolded proteins,
unassisted by chaperone HSP60 in stressed mitochondria, are
committed to be digested by proteases (Jovaisaite et al., 2014).
In this regard, the ORA analysis of the network statistically val-
idated the importance of the “response to unfolded protein” GO
term. Moreover, it highlighted the possible involvement of other
pathways possibly altered by MPP+, such as the mTOR signaling
cascade and the DNA repair pathway.
As far as the D1 model of the META list is concerned, the
significant results included once again the over-representation of
proteins acting at the synapse and implicated in the transport to
mitochondria. Again, the category “autophagic vacuole assembly”
linked to autophagy (e.g., the mTOR signaling cascade) appeared
to be over-represented. This observation is in agreement with
previous reports on the autophagy induction by MPP+ and its
ability to dysregulate the process, leading to unfolded proteins
and impaired mitochondria accumulation, and further ROS pro-
duction (Dagda et al., 2013). This is particularly important, since
neurons depend on autophagy for differentiation and survival
(Komatsu et al., 2006).
The simultaneous consideration of several proteome alter-
ations by the meta-analysis allowed us to define which pathways
are mainly influenced by MPP+. However, it is possible that
several proteins playing an important role in some of these pro-
cesses were not detected by any of the considered papers. The
reasons might be various. For example, all the proteomics stud-
ies included in the present work dealt with quantitative changes,
whereas the contribution of a protein can be determined by other
factors, e.g., post-translational modifications or cellular localiza-
tion. To this purpose, we generated the D2model of theMETA list
in order to further enrich the scenario. Nevertheless, it was neces-
sary to use a different strategy to analyze this extended network.
Using a network clustering algorithm, we were able to obtain sub-
networks that may represent highly interconnected proteins in
protein complexes or functional modules (Stelzl et al., 2005). The
ORA analysis suggested which signaling pathways may be altered
by MPP+, e.g., the Wnt signaling pathway, already described to
be involved in the MPTP-induced loss and repair of nigrostriatal
dopaminergic neurons (L’Episcopo et al., 2012).
The bioinformatics analysis presented here may have some
shortcomings. First of all, we decided to include only papers based
on unbiased proteomics experiments, thus ignoring information
coming from other kinds of methodological approaches. This
effort was done to complete the interpretation of data of each
single paper and to suggest a possible workflow to interpret the
long list of proteins normally resulting from proteomics studies.
Nevertheless, the neglected information was implicitly taken into
account when missing proteins were added by the enrichment
procedures. Another shortcoming of PPI graphs is their static
nature. On the contrary, interacting proteins are highly dynamic
structures, changing in time and space. Eventually, all the false
positive or negative data present in the databases are mirrored in
the networks built on those information. Being aware of the limits
of this approach, we succeeded to describe how the mitochondrial
toxin MPP+ alters the mitochondrial proteome, overcoming the
issues of every single methodology or model. In some cases, the
information obtained putting all the results together is more than
simply their sum. For example, the dysregulation at the synapse
level may be one of the leading event in describing MPP+ toxic-
ity. As a whole, this analysis clarified the cellular pathways altered
by MPP+ and how this toxic model can recapitulate some patho-
genetic events of PD. This may serve at one side to guide future
research on PD using these models and on the other side to
envisage new neuroprotective agents to revert the degenerative
process.
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